Full-Time

QC Analyst

Microbiology

Confirmed live in the last 24 hours

AbCellera Biologics

AbCellera Biologics

501-1,000 employees

Biotechnology firm specializing in therapeutic antibodies

AI & Machine Learning
Biotechnology
Healthcare

Compensation Overview

CA$79.9k - CA$99.9kAnnually

+ Equity + Annual Bonus

Senior

Vancouver, BC, Canada

Category
Biology Lab & Research
Biology & Biotech
Requirements
  • Bachelor’s degree and 5+ years of experience or master’s degree in a relevant scientific discipline and 3+ years of QC experience
  • Strong knowledge and experience in Good Manufacturing Practices (GMPs), QC microbiological testing and method qualification requirements
  • Experience with using Milliflex Oasis, Charles River Endosafe nexgen-MCS, LIMS, as well as basic benchtop techniques such as Gram staining, plate reading, vacuum filtration and LAL gel-clot
  • Excellent interpersonal skills, ability to work independently and in a team environment, detail oriented, organized and methodical in execution of tasks
  • Ability to problem solve with sound analytical thinking
Responsibilities
  • Providing microbial support for aseptic product manufacturing in a cGMP regulated environment
  • Performing site support activities such as environmental monitoring, compressed gas and water system sampling within the graded manufacturing area
  • Carrying out a variety of routine microbiological techniques on utilities including but not limited to bioburden, endotoxin, TOC, conductivity and growth promotion testing on incoming microbial media
  • Responsible for micro release testing on raw materials, in-process drug substance and final product samples
  • Evaluating and reviewing test results for conformance to appropriate specifications and highlighting any suspect results to the QC Lab Manager
  • Participating in identification, investigation (deviations/out of specifications) and resolution of problems in the microbiology lab
  • Authoring method verification protocols, SOPs, WIs and TMs based on industry standard compendial methods

AbCellera specializes in discovering and developing therapeutic antibodies for various diseases. The company uses a proprietary technology platform that combines different scientific methods to identify and create antibodies efficiently. Clients, including pharmaceutical companies and research institutions, partner with AbCellera to enhance their drug development processes. Unlike many competitors, AbCellera focuses on challenging targets that traditional methods struggle to address. The company aims to accelerate the development of new medicines through collaborations, generating revenue from discovery services, licensing agreements, and its own therapeutic programs.

Company Stage

IPO

Total Funding

$620.9M

Headquarters

Vancouver, Canada

Founded

2012

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

1%
Simplify Jobs

Simplify's Take

What believers are saying

  • Collaboration with Biogen could solve the blood-brain barrier challenge in neuroscience.
  • Partnerships with Viking and ArrowMark may diversify revenue and enhance market presence.
  • Expanded collaboration with Eli Lilly could advance immunology, cardiovascular, and neuroscience programs.

What critics are saying

  • Increased competition in T-cell engagers may impact AbCellera's market share.
  • Failure in Biogen collaboration could harm reputation and financial outcomes.
  • Peter Thiel's resignation may lead to strategic shifts affecting investor confidence.

What makes AbCellera Biologics unique

  • AbCellera excels in antibody discovery with a proprietary, integrated technology platform.
  • The company partners with leading firms like AbbVie and Eli Lilly for drug development.
  • AbCellera's focus on multiomics and AI enhances its drug discovery efficiency.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

Paid Sick Leave

Flexible Work Hours

Company Equity

Performance Bonus